H21.563

✓ Billable

Pupillary abnormality, bilateral

Diseases of the eye and adnexa (H00-H59)

Check This Code

❌ Excludes1

inherited

Rules inherited from parent codes in the hierarchy.

  • congenital deformity of pupil (Q13.2-)
  • corectopia (Q13.2)

⚠️ Excludes2

inherited

Rules inherited from parent codes.

  • sympathetic uveitis (H44.1-)

Clinical Description

ICD-10-CM code H21.563 represents pupillary abnormality, bilateral. This code falls under the Diseases of the eye and adnexa (H00-H59) classification. It is a billable/specific code valid for HIPAA-covered transactions as of October 1, 2025 (FY2026). This code can be used to indicate a diagnosis for reimbursement purposes on insurance claims.

This is a 7-character code at the 6th level of specificity. This is the most specific code available in this subcategory. Coders should note that H21.563 has 2 Excludes1 restriction(s) — codes that cannot be reported together on the same claim.

Frequently Asked Questions

What is ICD-10 code H21.563?

ICD-10-CM code H21.563 is "Pupillary abnormality, bilateral". It belongs to the category: Diseases of the eye and adnexa (H00-H59).

Is H21.563 a billable ICD-10 code?

Yes, H21.563 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

What codes are excluded with H21.563?

H21.563 has 2 Excludes1 rule(s). These codes are mutually exclusive and cannot be coded together on the same claim.

Can H21.563 be coded with other codes?

H21.563 has 1 Excludes2 note(s). These conditions can be coded together if both are documented in the patient record.

Related Codes in H21.56

Other codes in the same category that may be relevant for differential coding:

🧪 Validate Combinations

Add H21.563 to the Excludes Checker to validate against your full code list.

Open in Checker →

Code Information

CodeH21.563
BillableYes
ParentH21.56
CategoryDiseases of the eye and adnexa (H00-H59)
Excludes12 rule(s)
Excludes21 note(s)

Data Source

CMS ICD-10-CM 2026 Tabular List

Updated October 1, 2025 (FY2026)